ACELRX PHARMACEUTICALS INC's ticker is and the CUSIP is 00444T900. A total of 5 filers reported holding ACELRX PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $1,000 | -95.5% | 1,000 | -95.3% | 0.00% | – |
| Q3 2021 | $22,000 | -93.9% | 21,300 | -91.8% | 0.00% | – |
| Q2 2021 | $360,000 | -33.8% | 261,100 | -18.4% | 0.00% | -100.0% |
| Q1 2021 | $544,000 | +328.3% | 320,000 | +211.3% | 0.00% | – |
| Q4 2020 | $127,000 | -18.1% | 102,800 | -5.8% | 0.00% | – |
| Q3 2020 | $155,000 | +297.4% | 109,100 | +234.7% | 0.00% | – |
| Q2 2020 | $39,000 | -77.5% | 32,600 | -60.2% | 0.00% | -100.0% |
| Q4 2019 | $173,000 | -26.7% | 82,000 | -23.5% | 0.00% | -50.0% |
| Q3 2019 | $236,000 | +14.0% | 107,200 | +31.2% | 0.00% | 0.0% |
| Q2 2019 | $207,000 | -59.5% | 81,700 | -44.3% | 0.00% | -66.7% |
| Q1 2019 | $511,000 | +211.6% | 146,700 | +106.9% | 0.01% | +500.0% |
| Q4 2018 | $164,000 | -75.6% | 70,900 | -59.3% | 0.00% | -80.0% |
| Q3 2018 | $671,000 | +362.8% | 174,200 | +305.1% | 0.01% | +400.0% |
| Q2 2018 | $145,000 | -40.1% | 43,000 | -62.7% | 0.00% | -50.0% |
| Q1 2018 | $242,000 | +126.2% | 115,200 | +118.2% | 0.00% | +100.0% |
| Q4 2017 | $107,000 | +52.9% | 52,800 | +247.4% | 0.00% | 0.0% |
| Q3 2017 | $70,000 | +94.4% | 15,200 | -9.5% | 0.00% | – |
| Q2 2017 | $36,000 | +350.0% | 16,800 | +572.0% | 0.00% | – |
| Q1 2017 | $8,000 | +166.7% | 2,500 | +257.1% | 0.00% | – |
| Q3 2016 | $3,000 | -92.5% | 700 | -94.7% | 0.00% | -100.0% |
| Q1 2016 | $40,000 | -48.7% | 13,100 | -35.5% | 0.00% | 0.0% |
| Q4 2015 | $78,000 | -60.2% | 20,300 | -68.5% | 0.00% | -66.7% |
| Q3 2015 | $196,000 | -45.1% | 64,400 | -23.4% | 0.00% | -40.0% |
| Q2 2015 | $357,000 | +190.2% | 84,100 | +164.5% | 0.01% | +150.0% |
| Q1 2015 | $123,000 | +83.6% | 31,800 | +218.0% | 0.00% | +100.0% |
| Q4 2014 | $67,000 | -53.1% | 10,000 | -61.7% | 0.00% | -50.0% |
| Q3 2014 | $143,000 | -54.5% | 26,100 | -14.7% | 0.00% | -60.0% |
| Q2 2014 | $314,000 | -46.0% | 30,600 | -36.9% | 0.01% | -50.0% |
| Q1 2014 | $582,000 | +88.3% | 48,500 | +77.7% | 0.01% | +100.0% |
| Q4 2013 | $309,000 | +130.6% | 27,300 | +120.2% | 0.01% | +66.7% |
| Q3 2013 | $134,000 | +1388.9% | 12,400 | +1140.0% | 0.00% | – |
| Q2 2013 | $9,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|